160 related articles for article (PubMed ID: 25968921)
21. CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients.
Li DY; Teng RC; Zhu HJ; Fang Y
Int J Clin Pharmacol Ther; 2013 Jun; 51(6):466-74. PubMed ID: 23557867
[TBL] [Abstract][Full Text] [Related]
22. Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients.
Roy JN; Barama A; Poirier C; Vinet B; Roger M
Pharmacogenet Genomics; 2006 Sep; 16(9):659-65. PubMed ID: 16906020
[TBL] [Abstract][Full Text] [Related]
23. Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients.
Hosohata K; Uesugi M; Hashi S; Hosokawa M; Inui K; Matsubara K; Ogawa K; Fujimoto Y; Kaido T; Uemoto S; Masuda S
Drug Metab Pharmacokinet; 2014; 29(1):83-9. PubMed ID: 23955548
[TBL] [Abstract][Full Text] [Related]
24. Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients.
Gómez-Bravo MA; Apellaniz-Ruiz M; Salcedo M; Fondevila C; Suarez F; Castellote J; Rufian S; Pons JA; Bilbao I; Alamo JM; Millán O; Brunet M; Rodríguez-Antona C
Pharmacogenet Genomics; 2018 Feb; 28(2):41-48. PubMed ID: 29256966
[TBL] [Abstract][Full Text] [Related]
25. The POR rs1057868-rs2868177 GC-GT diplotype is associated with high tacrolimus concentrations in early post-renal transplant recipients.
Liu S; Chen RX; Li J; Zhang Y; Wang XD; Fu Q; Chen LY; Liu XM; Huang HB; Huang M; Wang CX; Li JL
Acta Pharmacol Sin; 2016 Sep; 37(9):1251-8. PubMed ID: 27498776
[TBL] [Abstract][Full Text] [Related]
26. CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation.
Hu R; Barratt DT; Coller JK; Sallustio BC; Somogyi AA
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):320-326. PubMed ID: 29603629
[TBL] [Abstract][Full Text] [Related]
27. Flucloxacillin decreases tacrolimus blood trough levels: a single-center retrospective cohort study.
Veenhof H; Schouw HM; Besouw MTP; Touw DJ; Gracchi V
Eur J Clin Pharmacol; 2020 Dec; 76(12):1667-1673. PubMed ID: 32712713
[TBL] [Abstract][Full Text] [Related]
28. The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.
Haufroid V; Mourad M; Van Kerckhove V; Wawrzyniak J; De Meyer M; Eddour DC; Malaise J; Lison D; Squifflet JP; Wallemacq P
Pharmacogenetics; 2004 Mar; 14(3):147-54. PubMed ID: 15167702
[TBL] [Abstract][Full Text] [Related]
29. Acute vasoreactivity testing with nicardipine in patients with pulmonary arterial hypertension.
Saito Y; Nakamura K; Miyaji K; Akagi S; Mizoguchi H; Ogawa A; Fuke S; Fujio H; Kiyooka T; Nagase S; Kohno K; Morita H; Kusano KF; Matsubara H; Ohe T; Ito H
J Pharmacol Sci; 2012; 120(3):206-12. PubMed ID: 23117888
[TBL] [Abstract][Full Text] [Related]
30. [Interaction between sildenafil and calcineurin inhibitors in renal transplant recipients with erectile dysfunction].
Cofán F; Gutiérrez R; Beardo P; Campistol JM; Oppenheimer F; Alcover J
Nefrologia; 2002; 22(5):470-6. PubMed ID: 12497749
[TBL] [Abstract][Full Text] [Related]
31. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M
Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597
[TBL] [Abstract][Full Text] [Related]
32. Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective.
Li JL; Wang XD; Chen SY; Liu LS; Fu Q; Chen X; Teng LC; Wang CX; Huang M
Pharmacogenomics J; 2011 Aug; 11(4):300-6. PubMed ID: 20514078
[TBL] [Abstract][Full Text] [Related]
33. Diltiazem increases tacrolimus concentrations.
Hebert MF; Lam AY
Ann Pharmacother; 1999 Jun; 33(6):680-2. PubMed ID: 10410178
[TBL] [Abstract][Full Text] [Related]
34. Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelines.
Elens L; Capron A; van Schaik RH; De Meyer M; De Pauw L; Eddour DC; Latinne D; Wallemacq P; Mourad M; Haufroid V
Ther Drug Monit; 2013 Oct; 35(5):608-16. PubMed ID: 24052064
[TBL] [Abstract][Full Text] [Related]
35. Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients.
Kagaya H; Niioka T; Saito M; Inoue T; Numakura K; Yamamoto R; Akamine Y; Habuchi T; Satoh S; Miura M
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29547545
[TBL] [Abstract][Full Text] [Related]
36. Tacrolimus toxicity due to drug interaction with mibefradil in a patient after liver transplantation.
Ocran KW; Plauth M; Mai I; Lochs H
Z Gastroenterol; 1999 Oct; 37(10):1025-8. PubMed ID: 10549098
[TBL] [Abstract][Full Text] [Related]
37. Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype.
Vanhove T; Annaert P; Lambrechts D; Kuypers DRJ
Pharmacogenomics J; 2017 Dec; 17(6):556-562. PubMed ID: 27378609
[TBL] [Abstract][Full Text] [Related]
38. Bradycardia caused by intravenous nicardipine in an elderly patient with acute ischemic infarct.
Abboud ME; Frasure SE
Am J Emerg Med; 2016 Apr; 34(4):761.e1-2. PubMed ID: 26371831
[TBL] [Abstract][Full Text] [Related]
39. Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.
Tsuchiya N; Satoh S; Tada H; Li Z; Ohyama C; Sato K; Suzuki T; Habuchi T; Kato T
Transplantation; 2004 Oct; 78(8):1182-7. PubMed ID: 15502717
[TBL] [Abstract][Full Text] [Related]
40. Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.
Hecht JP; Richards PG
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):460-465. PubMed ID: 29092768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
